Antoine A Ruzette

ORCID: 0009-0003-2203-0040
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Digestive system and related health
  • Mechanisms of cancer metastasis

Center for Systems Biology
2025

Harvard University
2025

In pancreatic ductal adenocarcinoma cancer (PDAC) drug resistance is a severe clinical problem and patients relapse within few months after receiving the standard-of-care chemotherapy. One contributing factor to treatment desmoplastic nature of PDAC; tumours are surrounded by thick layers stroma composing up 90% tumour mass. This stroma, which mostly comprised extracellular matrix (ECM) proteins, secreted cancer-associated fibroblasts (CAFs) residing in microenvironment. However, mechanistic...

10.1101/2025.01.22.634323 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-01-25

Aggressive cancers, such as pancreatic ductal adenocarcinoma (PDAC), are often characterized by a complex and desmoplastic tumor microenvironment rich in stroma, supportive connective tissue composed primarily of extracellular matrix (ECM) non-cancerous cells. Desmoplasia, which is dense deposition major reason for therapy resistance, acting both physical barrier that interferes with drug penetration niche protects cancer cells through diverse mechanisms. A precise understanding spatial cell...

10.1101/2025.04.28.650414 preprint EN cc-by 2025-05-01
Coming Soon ...